Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients \>= 25 years of age~* Type 2 diabetes for \>= 1 year~* Hemoglobin A1c \>= 7.5% and \<=11%~* Diabetes managed by exercise and diet, prescription oral medication or an injectable incretin mimetic~Exclusion Criteria:~* Type 1 diabetes~* On any type of insulin therapy at start of study

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active Control Group (ACG) (Type: OTHER): Participants in the Active Control Group received enhanced standard of care (more frequent clinic visits, free blood glucose meters and strips and point-of-care Hemoglobin A1c (HbA1c) test) for management of their Type 2 diabetes.
- Structured Testing Group (STG) (Type: EXPERIMENTAL): Participants in the Structured Testing Group in addition to enhanced standard of care for the treatment of their Type 2 diabetes used the ACCU-CHEK® 360° View blood glucose analysis system (Tool) to monitor glucose levels at least quarterly.

Based on this trial design, predict the completion outcome and termination type (if applicable).